Form D · Pharmaceuticals
Brickell Bay Acquisition Corp.
Miami, FL · CIK 0001475050
Offering snapshot reported Jan 25, 2010 · SEC filing
- Reported sold
- $52.4M Offering amount: $52.4M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2010 | Initial | $52,411,646 | No comparison | 38 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-138140
The company issued 35,000,017 shares of common stock, 48,912 shares of preferred stock to rollover investors in a merger, and warrants to purchase 3,711,341 shares of common stock and 3,340 shares of preferred stock to lenders.
Source: Form D, filed Jan 25, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig M. Kahler | Executive |
| Michael Moran | Director, Executive |
| William J. Nolan | Director, Executive |
| Richard Rosen | Executive |
| Brian D. Schwartz | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1001 Brickell Bay Drive 27 Th Floor
Miami, FL, 33131
Miami, FL, 33131